Related Experiment Video
Updated: Jun 25, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 23, 2013
Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview
1Institute of Medical Microbiology, Hygiene and Infectious Diseases, University Hospital Salzburg, Salzburg, Austria.
Abstract:
Owing to its unique host cell-dependent development cycle, Chlamydia pneumoniae occupies an intracellular niche that enables the bacterium to survive and to multiply, secluded from both the extracellular and the cytoplasmic environments. Within its separate chlamydial inclusion, it is able to genetically switch between a replicative and a persisting non-replicative state, linking the pathogen to acute as well as chronic diseases. Although its role in acute respiratory infection has been established, a potential link between chronic vascular infection with C. pneumoniae and the development of atherosclerosis remains enigmatic, in particular because chronic chlamydial infection cannot be eradicated by antibiotics. C. pneumoniae has developed numerous mechanisms to establish an adequate growth milieu involving the type III secretion-mediated release of chlamydial effector proteins that interact with cellular structures and reprogram host cell regulatory pathways. This brief overview of these pathomechanisms focuses on chronic vascular infection.
Insights
Chlamydia pneumoniae survives inside host cells, switching between growth and persistence states. This bacterium
Area of Science:
- Microbiology
- Pathogenesis
- Vascular Biology
Background:
- Chlamydia pneumoniae is an obligate intracellular bacterium with a unique developmental cycle.
- It establishes a niche within host cells, evading host defenses.
- The bacterium can transition between replicative and persistent states, contributing to acute and chronic diseases.
Purpose of the Study:
- To provide an overview of Chlamydia pneumoniae pathomechanisms.
- To focus on the bacterium's role in chronic vascular infection and atherosclerosis.
Main Methods:
- Review of existing literature on Chlamydia pneumoniae pathogenesis.
- Focus on type III secretion system and effector proteins.
Main Results:
- Chlamydia pneumoniae utilizes host cell-dependent mechanisms for survival and multiplication.
- The bacterium employs type III secretion to release effector proteins, reprogramming host cell pathways.
- Mechanisms facilitating chronic vascular infection remain under investigation.
Conclusions:
- Chlamydia pneumoniae's intracellular niche and developmental plasticity contribute to its pathogenicity.
- Understanding its pathomechanisms is crucial for addressing chronic vascular diseases like atherosclerosis.
- Further research is needed to elucidate the enigmatic link between chronic C. pneumoniae infection and atherosclerosis.
Related Concept Videos
Bacterial Phylum Chlamydiae
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease I: Introduction
Pneumonia II: Pathophysiology
